Quick Takeaways
- Catalent, Inc. has 42 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Apr 2025.
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Peter Zippelius |
3/4/5
|
Director |
—
class O/S missing
|
4,342,441
|
$161,451,956 | — | 27 Oct 2022 | |
| John R. Chiminski |
3/4/5
|
Executive Chair, Director |
—
class O/S missing
|
229,888
|
$8,547,236 | — | 24 Aug 2022 | |
| Steven L. Fasman |
3/4/5
|
EVP & Chief Admin Officer |
—
class O/S missing
|
72,380
|
$2,691,088 | — | 23 Aug 2023 | |
| Jonathan Arnold |
3/4/5
|
SVP, CCO & Div. Head BioP Del. |
—
class O/S missing
|
55,896
|
$2,078,213 | — | 23 Aug 2023 | |
| Ricardo Pravda |
3/4/5
|
Chief Transformation Officer |
—
class O/S missing
|
29,522
|
$1,097,628 | — | 23 Aug 2023 | |
| Madhavan Balachandran |
3/4/5
|
Director |
—
class O/S missing
|
27,441
|
$1,020,256 | — | 27 Oct 2023 | |
| Christa Kreuzburg |
3/4/5
|
Director |
—
class O/S missing
|
18,283
|
$921,646 | — | 25 Jan 2024 | |
| Karen Flynn |
3/4/5
|
Director |
—
class O/S missing
|
24,339
|
$904,924 | — | 27 Oct 2023 | |
| Rosemary A. Crane |
3/4/5
|
Director |
—
class O/S missing
|
23,873
|
$887,598 | — | 27 Oct 2023 | |
| Michael J. Grippo |
3/4/5
|
SVP, Strategy & Corp. Dev. |
—
class O/S missing
|
23,725
|
$882,096 | — | 23 Aug 2023 | |
| Thomas P. Castellano |
3/4/5
|
SVP, Chief Financial Officer |
—
class O/S missing
|
20,099
|
$747,281 | — | 24 Aug 2022 | |
| Kay A. Schmidt |
3/4/5
|
SVP, Enterprise Functions |
—
class O/S missing
|
17,388
|
$646,486 | — | 24 Aug 2022 | |
| Manja Boerman |
3/4/5
|
Pres. BioModalities Division |
—
class O/S missing
|
14,414
|
$535,913 | — | 01 May 2023 | |
| Patricia Hunt |
3/4/5
|
Pres. Consumer Health Div |
—
class O/S missing
|
11,267
|
$418,907 | — | 16 Oct 2023 | |
| Charles Lickfold |
3/4/5
|
SVP, CIO |
—
class O/S missing
|
10,892
|
$404,965 | — | 23 Aug 2023 | |
| Lorenzo Carletti |
3/4/5
|
SVP Global Ops Ph & Cons Hlth |
—
class O/S missing
|
8,505
|
$316,216 | — | 23 Aug 2023 | |
| Thomas W. Hawkeswood |
3/4/5
|
Pres. Pharma Prod Delivery Div |
—
class O/S missing
|
7,412
|
$275,578 | — | 23 Aug 2023 | |
| Michael A. Riley |
3/4/5
|
Pres. Bio Product Delivery Div |
—
class O/S missing
|
6,592
|
$245,091 | — | 26 Aug 2022 | |
| Ricardo Zayas |
3/4/5
|
SVP, Operations, Biologics NA |
—
mixed-class rows
|
16,101
mixed-class rows
|
$231,371 | — | 01 Aug 2023 | |
| Mario Gargiulo |
3/4/5
|
SVP, Ops, Biologics Europe |
—
class O/S missing
|
5,676
|
$211,034 | — | 01 May 2023 | |
| Karen Murphy Santiago |
3/4/5
|
VP & Chief Accounting Officer |
—
mixed-class rows
|
9,979
mixed-class rows
|
$177,088 | — | 01 Aug 2023 | |
| Ricci S. Whitlow |
3/4/5
|
President, CSS |
—
class O/S missing
|
2,923
|
$108,677 | — | 21 Jan 2022 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
—
class O/S missing
|
1
|
$63 | — | 31 Dec 2025 | |
| Michael Hatzfeld |
3/4/5
|
Chief Accounting Officer |
—
class O/S missing
|
3,981
|
— | — | 18 Dec 2024 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||